Freestone Capital Holdings’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-14
Closed -$2.44K 783
2020
Q4
$2.44K Hold
14
﹤0.01% 1112
2020
Q3
$2.26K Buy
+14
New +$2.22K ﹤0.01% 1017
2014
Q2
Sell
-5,074
Closed -$428K 236
2014
Q1
$428K Buy
+5,074
New +$405K 0.08% 140

Other funds holding LH

Freestone Capital Holdings's LH Position: Q1 2021 in Review

Freestone Capital Holdings sold out of Labcorp (LH) in Q1 2021, closing a stake of 14 shares — an estimated $2.44K sold.

Freestone Capital Holdings first reported a position in LH in Q1 2014 and held it in 3 quarters. The position peaked at $428K in Q1 2014. 920 funds tracked by Wall St. Rank hold LH as of Q1 2021.

  • Freestone Capital Holdings reported no remaining Labcorp position as of Q1 2021 after selling out during the quarter.
  • Freestone Capital Holdings sold 14 Labcorp shares in Q1 2021, an estimated $2.44K.
  • Freestone Capital Holdings first reported a position in Labcorp in Q1 2014 and held it in 3 quarters.
  • Freestone Capital Holdings's Labcorp position peaked at $428K in Q1 2014.
  • 920 funds tracked by Wall St. Rank held Labcorp as of Q1 2021.

Based on Freestone Capital Holdings's 13F filing for Q1 2021, filed 17 May 2021.